Short-Term Indicators Showing Strength for Humana Inc. (HUM)

HUNTER CHRISTOPHER H., Seg President, Group Business, subtracted 15,586 shares of Humana Inc. (HUM) from its portfolio at the rate of $305.24 per share valuing $4,757,430 on Feb 25. The insider left behind 12,785 shares of the company to its portfolio. Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of Humana Inc. (HUM) was $254.73. Currently, the 1st Resistance Point for this stock is $258.09, with a 2nd Resistance Point sitting at $261.46. Meanwhile, this company’s stock has a 1st Support Level at $248.32 and a 2nd Support Level at $241.92. Humana Inc. (HUM) stock has gained $7.88, or 3.19%, in the past five days. In the last full month, these shares have gained $19.05, or 8.08%. In the past three months, this stock’s price has fallen by -$28.30, or -10.00%. This year-to-date, Humana Inc. (HUM) shares have lost -$31.75, or -11.08%.

Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For Humana Inc. (HUM) stock, 40% of short-term indicators suggest that these shares are a “ Hold .” Meanwhile, 25% of medium-term indicators point to this stock being a “ Sell .” Looking further ahead, 67% of long-term indicators suggest that this stock is a “ Sell .”

With 135,035 K shares outstanding, this company currently has a market capitalization of $33,229,414K. Humana Inc. (HUM) generates $56,912 M in annual sales, amounting to annual net income of $1,683 M. This stock has generated a 1-Year Total Return of -16.87%, a 3-Year Total Return of 36.11%, and a 5-year Total Return of 100.34%. This stock’s 5-Year Dividend Growth is 44.86%, with its most recent dividend valued at $0.550 per share on 03/28/19. Its Annual Dividend Yield is 0.90%, and its Annual Dividend Rate is 2.20.

In the most recently-reported fiscal quarter, which ended in Mar-19, Humana Inc. (HUM) reported earnings of $4.48 per share. Wall Street analysts, on average, were expecting the company to report earnings of $4.30 per share, representing a 0.18 difference and 4.29% surprise. In the previous quarter ending in Dec-18, the reported earnings of $2.65 represented a 0.12 difference from the consensus estimate calling for $2.53 per share, which was a 4.76% surprise.

For the current fiscal quarter, which is set to end in 06/2019, the average earnings estimate is $5.24 per share. This estimate came from a total of 10 Wall Street Analysts. Of those market experts, the high estimate was $5.47 and the low estimate was $4.49. In the year-ago quarter, Humana Inc. (HUM) generated per-share earnings of $3.96. If the analysts are correct about the current quarter’s earnings, the growth will be +32.32% .

Turning our focus now to insider trading activity, there have been 0 purchases (0 shares in total) and 0 sale (0 shares in total) in the last 3 months. In the last 6 months, there have been 60 insider buys amounting to 150,721 shares and 63 insider sales amounting to 145,897 shares. In the past full year, 74 insider purchases were made (involving 220,407 shares) and 79 insider sell-offs equivalent to 242,174 shares.

Moving onto liquidity, Humana Inc. (HUM) has a Current Ratio of 1.42. Looking at this company’s capital structure, its Total Debt to Total Equity is 59.73, its Total Debt to Total Capital is 37.39, and its Total Debt to Total Assets is now 23.65. Looking even further ahead into the future, its Long-Term Debt to Equity is 43.06 and its Long-Term Debt to Total Capital is 26.96.